To hear about similar clinical trials, please enter your email below
Trial Title:
Digital Storytelling in Symptom Management Pediatric Oncology
NCT ID:
NCT06436651
Condition:
Child, Only
Cancer
Symptoms and Signs
Narration
Conditions: Keywords:
child
cancer
nursing
symptom management
digital storytelling
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Parallel Assignment
Primary purpose:
Supportive Care
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Intervention:
Intervention type:
Other
Intervention name:
Digital Storytelling
Description:
4 stages of digital storytelling will be implemented.
Arm group label:
Control group
Arm group label:
Experimental group
Summary:
The aim of this clinical study is to evaluate the effectiveness of the digital
storytelling method in symptom management in children diagnosed with oncology. It will
also provide information about children's experiences with Digital Storytelling and the
use of the method. The main questions it aims to answer are:
- Is there a difference between the anxiety scores of children who applied the Digital
Storytelling Method and those who did not?
- Is there a difference between the fatigue scores of children who applied the Digital
Storytelling Method and those who did not?
- Is there a difference between the nausea scores of children who applied the Digital
Storytelling Method and those who did not?
- Is there a difference between the pain scores of children who applied and did not
apply the Digital Storytelling Method?
Participants:
Complete the first stage data forms. Visit the clinic every 7-15 days for the digital
storytelling process, which consists of 4 stages. After the storytelling process is
completed, have a process evaluation meeting with the researcher.
Detailed description:
Participants; Enterprise Group,
1. Interview (Week 1); Meeting the child, conducting a qualitative interview for needs
analysis and introducing the forms
2. Interview (Week 2); Finding a digital story topic
3. Interview (Week 3); Writing a story on the specified topic
4. Interview (Week 4); Converting the story into digital form
5. Interview (Week 5); Showing the created story
6. Interview (Week 6); Conducting a qualitative interview regarding the digital
storytelling process.
Each meeting will be held in 1-week periods. Primary outcome tools will be applied as
pretest and posttest once in the 1st and 6th interviews, and twice in the other
interviews.
Control Group;
1. Interview (Week 1); Meeting the child, introducing and applying the forms
2. Interview (Week 6); Conducting a qualitative interview regarding the digital
storytelling process. Showing the videos prepared by the children in the initiative
group. Application of primary outcome tools.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- 7-18 years old,
- Having received at least 1 cure of treatment,
- Completed the induction phase and is in the consolidation phase,
- Children who and their parents agree to participate in the study.
Exclusion Criteria:
- who cannot speak Turkish,
- Having a secondary chronic disease
- Having a second disease that will affect the cognitive process,
- Children/adolescents who cannot complete the 4 stages of the digital storytelling
process.
- Children/adolescents who cannot complete the 4 stages of the digital storytelling
process.
- Children/adolescents who take a break of more than 3 weeks between storytelling
processes.
Gender:
All
Minimum age:
7 Years
Maximum age:
18 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Kocaeli Universıty
Address:
City:
Kocaeli
Country:
Turkey
Status:
Recruiting
Contact:
Last name:
Birgül Erdoğan, Msc
Phone:
0262 303 47 33
Email:
b.erdogan0816@gmail.com
Start date:
November 13, 2023
Completion date:
September 2024
Lead sponsor:
Agency:
Kocaeli University
Agency class:
Other
Collaborator:
Agency:
Gazi University
Agency class:
Other
Source:
Kocaeli University
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06436651
